{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:57:22Z","timestamp":1776128242537,"version":"3.50.1"},"reference-count":20,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.2176\/jns-nmc.2022-0375","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:58:26Z","timestamp":1697237906000},"page":"291-297","source":"Crossref","is-referenced-by-count":2,"title":["Neoadjuvant Therapy with Everolimus for Subependymal Giant Cell Astrocytoma: A Case Report"],"prefix":"10.2176","volume":"10","author":[{"given":"Hiroki","family":"KARITA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tokyo Metropolitan Children's Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoji","family":"TSUDA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Metropolitan Children's Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"KONO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Metropolitan Children's Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"YAMAMOTO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yokohama City University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"IHARA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Metropolitan Children's Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Krueger DA, Franz DN: Current management of tuberous sclerosis complex. Paediatr Drugs<\/i> 10: 299-313, 2008","DOI":"10.2165\/00148581-200810050-00004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Osborne JP, Fryer A, Webb D: Epidemiology of tuberous sclerosis. Ann N Y Acad Sci<\/i> 615: 125-127, 1991","DOI":"10.1111\/j.1749-6632.1991.tb37754.x"},{"key":"3","unstructured":"3) Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group: Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol<\/i> 49: 255-265, 2013"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ebrahimi-Fakhari D, Mann LL, Poryo M, et al.: Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis<\/i> 13: 117, 2018","DOI":"10.1186\/s13023-018-0870-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Goh S, Butler W, Thiele EA: Subependymal giant cell tumors in tuberous sclerosis complex. Neurology<\/i> 63: 1457-1461, 2004","DOI":"10.1212\/01.WNL.0000142039.14522.1A"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Adriaensen ME, Schaefer-Prokop CM, Stijnen T, Duyndam DA, Zonnenberg BA, Prokop M: Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol<\/i> 16: 691-696, 2009","DOI":"10.1111\/j.1468-1331.2009.02567.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Harter DH, Bassani L, Rodgers SD, et al.: A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. J Neurosurg Pediatr<\/i> 13: 21-28, 2014","DOI":"10.3171\/2013.9.PEDS13193"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Jiang T, Du J, Raynald , Wang J, Li C: Presurgical administration of mTOR inhibitors in patients with large subependymal giant cell astrocytoma associated with tuberous sclerosis complex. World Neurosurg<\/i> 107: 1053.e1-1053.e6, 2017","DOI":"10.1016\/j.wneu.2017.08.122"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Cheng S, Hawkins C, Taylor MD, Bartels U: Pathological findings of a subependymal giant cell astrocytoma following treatment with rapamycin. Pediatr Neurol<\/i> 53: 238-242.e1, 2015","DOI":"10.1016\/j.pediatrneurol.2015.05.020"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Crino PB, Nathanson KL, Henske EP: The tuberous sclerosis complex. N Engl J Med<\/i> 355: 1345-1356, 2006","DOI":"10.1056\/NEJMra055323"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Franz DN, Bissler JJ, McCormack FX: Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics<\/i> 41: 199-208, 2010","DOI":"10.1055\/s-0030-1269906"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) European Chromosome 16 Tuberous Sclerosis Consortium: Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell<\/i> 75: 1305-1315, 1993","DOI":"10.1016\/0092-8674(93)90618-Z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) van Slegtenhorst M, de Hoogt R, Hermans C, et al.: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science<\/i> 277: 805-808, 1997","DOI":"10.1126\/science.277.5327.805"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Krueger DA, Care MM, Holland K, et al.: Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med<\/i> 363: 1801-1811, 2010","DOI":"10.1056\/NEJMoa1001671"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Roth J, Roach ES, Bartels U, et al.: Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol<\/i> 49: 439-444, 2013","DOI":"10.1016\/j.pediatrneurol.2013.08.017"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kotulska K, Borkowska J, Roszkowski M, et al.: Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Pediatr Neurol<\/i> 50: 307-312, 2014","DOI":"10.1016\/j.pediatrneurol.2013.12.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Cuccia V, Zuccaro G, Sosa F, Monges J, Lubienieky F, Taratuto AL: Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv Syst<\/i> 19: 232-243, 2003","DOI":"10.1007\/s00381-002-0700-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Berhouma M: Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective. World J Pediatr<\/i> 6: 103-110, 2010","DOI":"10.1007\/s12519-010-0025-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Moavero R, Pinci M, Bombardieri R, Curatolo P: The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective. Childs Nerv Syst<\/i> 27: 1203-1210, 2011","DOI":"10.1007\/s00381-011-1406-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Arena C, Bizzoca ME, Caponio VCA, et al.: Everolimus therapy and side-effects: a systematic review and meta-analysis. Int J Oncol<\/i> 59: 1-9, 2021","DOI":"10.3892\/ijo.2021.5234"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/10\/0\/10_2022-0375\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:08:21Z","timestamp":1697260101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/10\/0\/10_2022-0375\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,31]]},"references-count":20,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2022-0375","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,31]]},"article-number":"2022-0375"}}